Healthy Ideas, Healthy Returns
The cross-border platform of Life Science professionals supporting academic spin-off development in Biotech, Medtech and Digital health in the BeNeLux
Your place to tap into the Human Health community of knowledge institutes, spin-off initiatives, investors, industry partners and expert service providers in the Netherlands, Belgium and Luxemburg.
Our practitioner-driven network unites nearly 100 TTO professionals, investors, spin-offs and biopharmaceutical firms across the Benelux, establishing HIHR as a leader in early-stage healthcare venture development. We host targeted events that bridge the gap between academic research, investors, and entrepreneurs to catalyse promising business ideas.
We are:
• Hands on / small scale / neutral
• Independent, flexible, decisive and effective
• Content-focused, collaborative, professional & trustworthy
Milestone reached: more than 250 academic spin off projects have been supported by HIHR
Since we started in 2016 we have helped more than 250 projects (261, to be precise) with strategic advice, presentation skills and network introductions.
About 85% has raised funding or is in the process of further development.

Nice balance between Biotech and Medtech, with Digital Health coming up

We invite all stakeholders in academic venture development to join our platform:
Public Research Organisations (PRO’s)
Over 95% of technology transfer offices (TTOs) in the Human Health and Life Sciences sector are active members, leveraging our network to support their emerging spin-offs. We empower these academic entrepreneurs through expert-led sessions, pitch training, and webinars that provide practical, actionable feedback.
Investors & industry partners
Investors join our network for exclusive, early-stage access to the Benelux region’s most promising human health innovations. We provide a unique “sneak peek” into emerging spin-offs from all major research institutes, ensuring they are vetted and coached before they take the stage. Through our informal “Quickfire” sessions and events, members gain high-quality deal flow and the opportunity to engage with investment-ready founders at the earliest possible stage.
Competence providers
Service providers gain exclusive access to the critical transition from R&D to market-ready startups. By building direct lines to Benelux technology transfer offices (TTOs), members can engage with high-potential spin-offs at their inception. Beyond early-stage project flow, the HIHR network facilitates strategic connections with leading VCs and industry giants, positioning your organization as a key partner in transforming academic research into medical breakthroughs.
Spin-off initiatives
Joining the network provides spin-offs with a direct bridge from the lab to the market. Founders gain exclusive access to a premier circle of investors and industry partners, complemented by intensive, tailor-made coaching. Through hands-on feedback and specialized pitch preparation, ventures are perfectly positioned to engage with leading medical innovation experts and secure critical growth milestones.

HIHR helped us enormously in improving our pitch.

At HIHR 2019 we had the opportunity as an academic team to pitch our spin-off project to a group of investors. After teaming up with an experienced entrepreneur and thorough due diligence, we successfully secured funding from some of those investors.

Great opportunity to get honest feedback from a great panel of experts and investors, even for projects in a rather early stage (QF Sessions).

As an early stage investor, HIHR is a unique opportunity to meet entrepreneurs in life sciences that are motivated to bring their work to patients. In addition, the meeting clearly has an objective to have benefits for all involved. I learned a lot from both presenters as well as questions from the audience.
Participating Public Research Organisations
Partnerships
Other participating funds
Many leading funds and venture developers are participating in our events. Find out here the list of all investors and industry partners that have joined our pitch sessions.




